Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment.
Saved in:
| Title: | Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment. |
|---|---|
| Authors: | Podder V; Mount Sinai Medical Center, Division of Gynecologic Oncology, Miami Beach, FL, USA., Grisham RN; Memorial Sloan Kettering Cancer Center, Department of Medicine, Gynecologic Medical Oncology Service, New York, NY, USA., Coleman RL; Texas Oncology, Gynecologic Oncology, The Woodlands, TX, USA., Cobb LP; University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA., Monk BJ; Florida Cancer Specialists and Research Institute, Division of Gynecologic Oncology, West Palm Beach, FL, USA., Herzog TJ; University of Cincinnati Cancer Center, Division of Gynecologic Oncology, Cincinnati, OH, USA., Gershenson DM; University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA., Slomovitz BM; Mount Sinai Medical Center, Division of Gynecologic Oncology, Miami Beach, FL, USA. Electronic address: brian.slomovitz@msmc.com. |
| Source: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2025 Dec; Vol. 35 (12), pp. 101938. Date of Electronic Publication: 2025 May 15. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
